Baldry Mark

Track

Insider profile

Baldry Mark's trades of X4 Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned purchase
Price
424.32
Quantity 47,961 +19.8%
Value US$768,972
Transaction date
Planned sale
Price
183.89
Quantity 60,747 +19.3%
Value US$2,268,231
Transaction date
Proposed sale
Price
248.42
Quantity 47,812
Value US$3,693,320
Transaction date
Proposed sale
Price
0.64
Quantity 11,127
Value US$7,083
Transaction date
Proposed sale
Price
0.79
Quantity 10,257
Value US$8,144
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-20 2025-05-16
PP Planned purchase
47,961 +19.8%
424.32
US$768,972 		47,961 +19.8% 424.32 US$768,972
2025-01-27 2025-01-24
PlS Planned sale
60,747 +19.3%
183.89
US$2,268,231 		60,747 +19.3% 183.89 US$2,268,231
2025-01-24 2025-01-24
PrS Proposed sale
47,812
248.42
US$3,693,320 		47,812 248.42 US$3,693,320
2024-10-08 2024-10-07
PlS Planned sale
11,127 -18.7%
0.58
US$6,506 		11,127 -18.7% 0.58 US$6,506
2024-10-07 2024-10-07
PrS Proposed sale
11,127
0.64
US$7,083 		11,127 0.64 US$7,083
2023-11-03 2023-11-01
PlS Planned sale
10,257 -29.4%
0.73
US$7,488 		10,257 -29.4% 0.73 US$7,488
2023-11-01 2023-11-01
PrS Proposed sale
10,257
0.79
US$8,144 		10,257 0.79 US$8,144